Recombinant Vaccinia virus Protein E8 (VACWR064)

When is Protein E8 expressed during viral infection, and where is it localized?

Contrary to earlier reports suggesting early expression, definitive research has established that Protein E8 is expressed predominantly late during infection. Western blot analyses have demonstrated that E8 appears at approximately 6 hours post-infection and persists throughout the infection course . This late expression pattern was confirmed by experiments using cytosine arabinoside (CAR), which inhibits DNA replication and subsequent late gene expression. In these experiments, E8 displayed inhibition patterns similar to other known late proteins like L4 .

Regarding localization, electron microscopy of labeled cryosections revealed that E8:

• Localizes to the endoplasmic reticulum (ER) and to membranes on one side of the Golgi complex as early as 1 hour post-infection

• Associates with membranes of immature virions and with intracellular mature viruses late in infection

• Becomes incorporated into viral cores during virion assembly

The protein's presence in multiple cellular and viral compartments suggests diverse functional roles during the viral life cycle.

How can recombinant Vaccinia virus Protein E8 be expressed and purified?

For recombinant expression of Protein E8, several systems have been documented:

• For His-tagged protein: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin

• Typical storage buffer: Tris/PBS-based buffer, 6% Trehalose, pH 8.0

• Recommended reconstitution: In deionized sterile water to 0.1-1.0 mg/mL

• Storage recommendation: Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C

Quality assessment: Purity of recombinant protein is typically confirmed by SDS-PAGE (≥85-90% purity) .

What are the functional roles of Protein E8 in the Vaccinia virus life cycle?

Protein E8 serves multiple functions during the Vaccinia virus life cycle, as revealed through studies of temperature-sensitive mutants and biochemical analyses:

Core functional roles:

• Virion core structure: E8 plays a subtle but critical role in virion core structure that directly or indirectly impacts core transcription .

• Virion infectivity: Mutants with reduced E8 incorporation (Dts23) or lacking E8 (Cts19) show significantly reduced infectivity. Purified Dts23 virions produced at non-permissive temperature (39.7°C) contain reduced amounts of E8 and have a high particle-to-infectivity ratio .

• Transcriptional activity: Dts23 virions grown at non-permissive temperature could enter cells but failed to synthesize early mRNA. Soluble extracts from mutant virions retained in vitro transcription activity, yet intact mutant cores were defective in transcription .

• DNA-membrane interactions: E8 potentially mediates the binding of viral DNA to ER membranes throughout the viral life cycle. During early infection, newly synthesized E8 may facilitate binding of parental DNA (released from the core) to ER membranes. Later, it may mediate binding of more ER cisternae to newly synthesized DNA, leading to near-complete enclosure of replication sites by ER membranes .

• Host-virus protein interactions: Yeast two-hybrid screening identified 27 candidate human proteins that interact with WR064 (COP-E8), suggesting multiple roles in virus-host interactions .

These findings collectively suggest that E8 is multifunctional, playing essential roles in virion structure, infectivity, transcription, and potentially in organizing viral replication complexes.

How do temperature-sensitive mutations in E8R affect Vaccinia virus replication?

Two well-characterized temperature-sensitive (ts) mutants of E8R provide valuable insights into protein function:

Dts23 mutation features:

• Contains a C to T transition at nucleotide 241, causing a leucine to phenylalanine substitution at codon 81 (L81F)

• Shows normal patterns of gene expression and DNA replication at both permissive (31°C) and non-permissive (39.7°C) temperatures

• Produces reduced levels of E8 protein at both temperatures

• Forms morphologically normal virus particles under non-permissive conditions

• Virions produced at non-permissive temperature have significantly reduced infectivity and transcriptional activity

Cts19 mutation features:

• Contains a G to A transition at nucleotide 3, replacing the initiating methionine with isoleucine (M1I)

• Shows no E8 protein synthesis at any time during infection

• Fails to produce identifiable viral structures when incubated at non-permissive temperature

• Produces virions at permissive temperature (31°C) but with reduced infectivity and no detectable E8

Comparative growth kinetics:

These mutants demonstrate that E8 is essential for productive viral infection, particularly for producing infectious particles with functional cores capable of early gene transcription upon infection.

What methods are available for studying DNA-binding properties of Protein E8?

The DNA-binding properties of Protein E8 can be investigated using several methodological approaches:

1. Electrophoretic Gel Mobility Shift Assay (EMSA):

• In vitro technique to assess protein-DNA interactions

• Procedure: Incubate purified GSTE8R or GSTNE8R (N-terminal 120 amino acids) with radiolabeled oligonucleotides

• Detection: Resolve protein-DNA complexes from free DNA by gel electrophoresis

• Findings: Both full-length E8 and its N-terminal domain bind DNA in vitro

2. Phosphorylation-modulated DNA binding:

• To study effects of phosphorylation on DNA binding

• Procedure: Pre-incubate GSTE8R/GSTNE8R with viral kinase F10L and ATP before adding labeled DNA

• Detection: Analyze protein-DNA complexes by EMSA

• Findings: Phosphorylation by F10L significantly reduces DNA binding capacity of E8

3. Chromatin Immunoprecipitation (ChIP):

• For studying in vivo DNA binding

• Procedure: Crosslink protein-DNA complexes in infected cells, immunoprecipitate with anti-E8 antibodies, recover and analyze bound DNA

• Application: Identifying viral or cellular DNA sequences bound by E8 during infection

4. Fluorescence microscopy with co-localization studies:

• For visualizing E8-DNA interactions in cells

• Procedure: Double-labeling of E8 protein and viral DNA in infected cells

• Analysis: Confocal microscopy to assess co-localization patterns

These complementary approaches allow comprehensive characterization of both in vitro and in vivo DNA-binding properties of Protein E8, providing insights into its functional roles in viral replication.

How should researchers design experiments to study E8 protein modifications during infection?

Experimental design for studying E8 modifications during infection should employ multiple complementary approaches:

Two-dimensional gel electrophoresis approach:

• Sample preparation:

  • Infect cells with Vaccinia virus at desired MOI

  • Harvest cells at different time points (early: 1-4h; late: 6-24h post-infection)

  • Prepare samples with or without inhibitors (e.g., hydroxyurea for blocking DNA replication)

  • For virion analysis, purify virions using sucrose gradient centrifugation

• 2D gel electrophoresis:

  • First dimension: Isoelectric focusing (pH 3-10)

  • Second dimension: SDS-PAGE (10-12%)

  • Controls: Compare patterns between different infection stages and purified virions

• Detection methods:

  • Western blotting with anti-E8 antibodies

  • For metabolic labeling: Infect cells, pulse-label with [35S]methionine at different times

  • Phosphorylation studies: Use 32P-orthophosphate labeling or phospho-specific antibodies

Analysis of results:

• Track changes in molecular weight and isoelectric point

• Compare modifications between different stages of infection

• Identify virion-specific modifications

Research has shown that E8 appears as a single spot throughout the VV life cycle on 2D gels, but in assembled virions, it undergoes several modifications resulting in changes to both molecular weight and isoelectric point . Some modifications appear to be phosphorylation events, potentially mediated by the viral F10L kinase.

What approaches can be used to identify and validate protein-protein interactions involving E8?

Multiple complementary approaches should be employed to identify and validate protein-protein interactions involving E8:

Identification strategies:

• Yeast Two-Hybrid (Y2H) screening:

  • Clone E8R into a DNA-binding domain vector (e.g., pGBT.superB)

  • Screen against human cDNA libraries (from various tissues and cell lines)

  • Previous Y2H screening identified 27 candidate human proteins interacting with WR064 (COP-E8)

• Co-immunoprecipitation from infected cells:

  • Infect cells with Vaccinia virus

  • Lyse cells and immunoprecipitate with anti-E8 antibodies

  • Identify co-precipitating proteins by mass spectrometry

• Proximity labeling approaches:

  • Express E8 fused to BioID or APEX2

  • Proximity-dependent biotinylation of interacting proteins

  • Purify biotinylated proteins and identify by mass spectrometry

Validation methods:

• GST pull-down assays:

  • Express E8 as GST fusion protein

  • Incubate with cell lysates or purified candidate proteins

  • Detect binding by Western blot

  • Previous validation studies showed a 63% confirmation rate for Y2H hits using GST pull-down assays

• Co-localization by immunofluorescence:

  • Co-stain infected cells for E8 and candidate interacting proteins

  • Analyze spatial overlap using confocal microscopy

• Bimolecular Fluorescence Complementation (BiFC):

  • Fuse E8 and candidate protein to complementary fragments of fluorescent protein

  • Interaction brings fragments together, reconstituting fluorescence

• FRET/FLIM analysis:

  • Label E8 and partner with fluorophores suitable for FRET

  • Measure energy transfer as evidence of close proximity

Using multiple orthogonal techniques increases confidence in identified interactions. For the highest confidence, researchers should aim to validate interactions using at least two independent methods.

How can researchers differentiate between direct and indirect effects in E8 mutant phenotypes?

Differentiating between direct and indirect effects in E8 mutant phenotypes requires a systematic experimental approach:

1. Complementation analysis:

• Express wild-type E8 in cells infected with E8 mutants

• Assess rescue of mutant phenotypes

• Use different promoters (early vs. late) to control timing of expression

• Example: In studies of Cts19 mutant, rescue was achieved using an amplicon containing both E7R and E8R genes

2. Domain-specific mutations:

• Create a panel of mutants targeting specific functional domains

• Design mutations that specifically affect one property without disrupting others

• Compare phenotypes between mutants affecting different domains

• Example: Compare mutations in DNA-binding domain vs. membrane-association domains

3. Temporal analysis of defects:

• Monitor sequential steps in viral replication

• Determine earliest detectable defect in mutants

• Example: Analysis of Dts23 showed normal DNA replication but defective virion transcriptional activity

4. Biochemical separation of functions:

• Perform in vitro assays with purified components

• Test specific activities (DNA binding, protein interaction, etc.)

• Example: Soluble extracts from Dts23 mutant virions maintained in vitro transcription activity, while intact cores were defective

5. Structure-function correlation:

• Align observed phenotypes with protein structural features

• Use computational prediction to identify critical residues

• Example: The L81F mutation in Dts23 likely affects a structural feature important for core function rather than expression level

This multi-faceted approach allows researchers to build a comprehensive model of E8 function and distinguish primary (direct) effects of mutations from secondary consequences.

How do researchers reconcile contradictory findings regarding the temporal expression pattern of E8?

The scientific literature contains contradictory findings regarding when E8 is expressed during viral infection. Resolving these contradictions requires careful methodological consideration:

Contradictory findings:

• Early reports by Doglio et al. (2002) suggested E8 is expressed early during infection

• Later studies by Condit and colleagues (2007) demonstrated that E8 is a late gene product

Methodological approaches to resolve the contradiction:

• Rigorous temporal analysis:

  • Precise time-course experiments with samples collected at frequent intervals

  • Western blot analysis using validated antibodies

  • Compare E8 expression with known early (e.g., F11) and late (e.g., L4) markers

  • Results: E8 appears at 6 hours post-infection, consistent with late expression

• Use of metabolic inhibitors:

  • Cytosine arabinoside (CAR) to block DNA replication and subsequent late gene expression

  • Compare protein synthesis in presence/absence of inhibitor

  • Results: E8 synthesis was inhibited by CAR, confirming late expression pattern similar to known late protein L4

• Promoter sequence analysis:

  • Examination of E8R gene revealed presence of two early transcription termination sequences embedded within coding sequence

  • Identified sequence consistent with intermediate or late gene promoter upstream of coding sequence

  • Supports classification as a late gene

The consensus based on these approaches is that E8R is a post-replicative (late) gene, contrary to earlier reports. This finding has been independently confirmed by other researchers (R. Jeremy Nichols and P. Traktman) . The contradictory results may have stemmed from antibody cross-reactivity issues or differences in experimental systems.

What are the methodological challenges in studying membrane-associated viral proteins like E8?

Studying membrane-associated viral proteins like E8 presents several methodological challenges that require specialized approaches:

1. Protein extraction and solubilization challenges:

• Membrane proteins are often difficult to extract in native conformation

• Solution: Use appropriate detergents (non-ionic such as NP-40, Triton X-100, or zwitterionic detergents like CHAPS)

• For E8 specifically: NP-40-dithiothreitol treatment has been used successfully to extract E8 while studying core association

2. Expression and purification difficulties:

• Recombinant expression often yields poor results in bacterial systems

• Observed issue: "We tried to express and purify GSTE8R from E. coli, but the yields of the protein were always very poor"

• Solutions:

  • Express in eukaryotic systems (insect cells with baculovirus)

  • Express soluble domains separately

  • Use specialized bacterial strains designed for membrane proteins

3. Localization studies complexities:

• Multiple subcellular localizations complicate interpretation

• E8 localizes to ER, Golgi, immature virions, mature virions, and cores

• Solution: Use high-resolution techniques:

  • Immuno-electron microscopy of cryosections

  • Super-resolution fluorescence microscopy

  • Correlative light and electron microscopy (CLEM)

4. Functional studies challenges:

• Separating membrane-association functions from other activities

• E8 has dual functions: membrane association and DNA binding

• Solution: Domain-specific mutations and fusion proteins to specifically disrupt one function while preserving others

5. Post-translational modification analysis:

• Modified forms often exist in small quantities

• Solution: Enrichment strategies:

  • 2D gel electrophoresis followed by Western blotting

  • Phospho-specific antibodies

  • Mass spectrometry with enrichment for modified peptides

Addressing these challenges requires combining multiple complementary approaches and often developing protein-specific protocols tailored to the unique properties of E8.

What are the current limitations in understanding the role of E8 in viral-host protein interactions?

Current understanding of E8's role in viral-host protein interactions has several significant limitations that present opportunities for future research:

1. Incomplete validation of interaction partners:

• Y2H screening identified 27 potential human protein partners for E8

• Limitation: Most interactions await validation by orthogonal methods

• Future direction: Systematic validation using complementary techniques (Co-IP, FRET, etc.)

2. Functional significance of interactions:

• Limitation: Biological relevance of most identified interactions remains unknown

• Current gap: How interactions contribute to viral replication or host response

• Research opportunity: Knockdown/knockout studies of interaction partners to assess effects on viral replication

3. Context-dependency of interactions:

• Limitation: Most interaction studies conducted outside natural infection context

• Research need: Study interactions during different stages of viral infection

• Approach: Time-resolved interactome analysis during infection cycle

4. Structural basis of interactions:

• Limitation: No structural data available for E8-host protein complexes

• Knowledge gap: How E8 domains contribute to specific interactions

• Future direction: Structural studies using X-ray crystallography or cryo-EM

5. Species-specificity considerations:

• Limitation: Most studies focus on human interactions

• Research opportunity: Comparative analysis across host species

• Relevance: Understanding host range determinants and species-specific pathogenesis

6. Integration with phosphorylation state:

• Current understanding: E8 can be phosphorylated by viral kinase F10L

• Knowledge gap: How phosphorylation affects host protein interactions

• Research approach: Compare interactome of phosphorylated vs. non-phosphorylated E8

Addressing these limitations will require integrative approaches combining proteomics, structural biology, and functional genomics to build a comprehensive model of how E8 interfaces with host systems during infection.

What emerging technologies could advance the understanding of E8 function in viral replication?

Several emerging technologies hold promise for deepening our understanding of E8's functions:

1. CRISPR-based technologies:

• CRISPR interference (CRISPRi) for temporal control of E8 expression

• CRISPR activation (CRISPRa) for controlled overexpression

• CRISPR screening to identify host factors that interact with E8 function

• Application: Identify host dependency factors specifically relevant to E8 function

2. Advanced imaging technologies:

• Live-cell super-resolution microscopy to track E8 dynamics during infection

• Lattice light-sheet microscopy for 3D visualization of E8 distribution

• Correlative light and electron microscopy (CLEM) to link functional observations with ultrastructural context

• Application: Visualize real-time recruitment of E8 to replication sites and viral assembly areas

3. Proximity labeling proteomics:

• TurboID or APEX2 fusions with E8 for rapid biotin labeling of proximal proteins

• Spatially and temporally resolved interactome mapping

• Application: Identify transient interactions missed by traditional approaches, map E8's changing interaction network during infection progression

4. Cryo-electron tomography:

• Structural analysis of E8 in native virion and cellular contexts

• Application: Determine precise localization and structural arrangement of E8 within viral cores

5. Single-molecule approaches:

• Single-molecule tracking to monitor E8 movement within infected cells

• DNA curtain assays to visualize E8-DNA interactions at single-molecule resolution

• Application: Characterize the dynamics and kinetics of E8's interaction with viral DNA

6. Synthetic biology approaches:

• Minimal systems reconstructing E8 function in artificial membranes

• In vitro reconstitution of DNA-membrane tethering

• Application: Define minimal components needed for E8's membrane-DNA bridging function

These technologies, especially when used in combination, have the potential to resolve long-standing questions about E8's multifunctional roles in the viral life cycle.

How might understanding E8 function contribute to poxvirus-based therapeutic applications?

Understanding E8 function has several potential applications for poxvirus-based therapeutics:

1. Development of attenuated viral vectors:

• Engineering E8 mutations that maintain vector viability but reduce pathogenicity

• Targeted modifications based on temperature-sensitive mutant studies (e.g., Dts23, Cts19)

• Application: Safer poxvirus-based vaccine vectors and oncolytic viruses

2. Design of antivirals targeting E8 function:

• Small molecule inhibitors disrupting E8-DNA interactions or E8 phosphorylation

• Peptide inhibitors targeting E8-host protein interactions

• Application: Novel antivirals against poxviruses, potentially with broad-spectrum activity

3. Exploitation of E8's membrane-organizing properties:

• Engineering E8 variants with enhanced ability to create membrane-enclosed compartments

• Application: Improved delivery systems for gene therapy or cancer treatment

4. Targeting E8-dependent host pathways:

• Identifying druggable host factors in E8 interaction network

• Application: Host-directed therapies with potentially higher barrier to resistance

5. Structure-based immunogen design:

• Using structural knowledge of E8 to design stable immunogens

• Application: Vaccines targeting conserved epitopes in orthologous proteins across poxvirus species

6. Diagnostic applications:

• Development of assays detecting E8 or anti-E8 antibodies

• Application: Improved diagnostics for poxvirus infections

The multifunctional nature of E8 makes it a particularly interesting target for intervention, as disrupting its activity could potentially impact multiple steps in the viral life cycle simultaneously.